Mega-Cap Stocks After February's: Top AI Picks Now
A February pullback gave investors a clearer path to big AI winners. Here are three mega-cap picks, plus concrete ste...
Credit cards come with a variety of benefits that can enhance your financial decisions. Discover the perks available to cardholders.
17,064 articlesA February pullback gave investors a clearer path to big AI winners. Here are three mega-cap picks, plus concrete ste...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
New guidance on supplement timing says the best time take your vitamins depends on vitamin type and possible interact...
SanDisk shares jumped about 6% on Friday as a persistent NAND shortage supports higher prices and prolonged demand fr...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Lucid Group faces a bumpy road as the EV market evolves. This report outlines 2026-2030 price paths for lucid group (...
A high-quality stock has endured a 19% drop over seven months. This article breaks down how to tell whether the decli...
A sharp dip can set off alarm bells, but it can also open doors. This article digs into why Qualcomm stock down 28% h...
Looking for long-term oil exposure you can ride through cycles? Discover why ExxonMobil and Chevron are strong candid...
Two popular total stock market ETFs—SCHB and VTI—offer broad U.S. exposure with ultra-low costs. This guide breaks do...
A clear, investor-friendly breakdown of Primoris' Q1 2026 earnings. Learn what drove results, how to read backlog and...